| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,839 |
39,045 |
$2.56M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
20,118 |
18,268 |
$624K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,831 |
7,552 |
$533K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,793 |
9,923 |
$247K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,616 |
12,841 |
$162K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,505 |
3,241 |
$121K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,181 |
1,111 |
$91K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,877 |
1,866 |
$86K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,929 |
1,847 |
$77K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,671 |
5,338 |
$71K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
227 |
220 |
$24K |
| 99201 |
|
714 |
698 |
$22K |
| 87807 |
|
1,950 |
1,845 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
285 |
246 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
436 |
383 |
$7K |
| 81002 |
|
2,583 |
2,388 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,995 |
2,662 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,883 |
4,563 |
$5K |
| 0012A |
|
41 |
41 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
49 |
49 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
80 |
70 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
454 |
400 |
$729.41 |
| 0011A |
|
41 |
39 |
$528.70 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29 |
29 |
$154.66 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$104.57 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
13 |
13 |
$7.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$0.57 |